Characteristics | Low-dose group | Standard-dose group |
---|---|---|
(n = 47) | (n = 48) | |
Age, mean (SD), y | 49.3 (10.2) | 48.2 (11.5) |
Sex | ||
Male n (%) | 36 (76.6%) | 29 (60.4%) |
Female n (%) | 11 (23.4%) | 19 (39.6%) |
Weight, mean (SD), kg | 72 (14) | 69 (16) |
Serum creatinine, mean (SD), μmol/L | 1247 (44.2) | 126.5 (47.8) |
Delay to cyclosporine A (CsA) use, mean (SD), d | 1.9 (1) | 1.9 (1) |
Pre-transplantation on heart disease: | ||
Idiopathic, n (%) | 18 (38.3%) | 18 (37.5%) |
Coronaropathy, n (%) | 16 (34%) | 18 (37.5%) |
Congenital cardiopathy, n (%) | 2 (4.3%) | 3 (63.3%) |
Valvular pathology, n (%) | 1 (2.1%) | 3 (63.3%) |
Other, n (%) | 10 (21.3%) | 6 (12.5%) |
Cytomegalovirus serology | ||
Donor+/Recipient-, n (%) |